Greenyn Biotechnology Co., Ltd (TPEX:6846)
Taiwan · Delayed Price · Currency is TWD 58.30
+0.60 (1.04%)
Oct 8, 2026, 11:09 AM CST
Greenyn Biotechnology Market Cap
Greenyn Biotechnology has a market cap or net worth of 1.57 billion as of October 9, 2026. It is the 30,544th most valuable company in the world and the 1,806th biggest in Taiwan. Its market cap has decreased by 24.19% in one year.
Market Cap
1.57B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#1,806 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since April 19, 2022, Greenyn Biotechnology's market cap has decreased from 2.03B to 1.57B, a decrease of -22.33%. That is a compound annual growth rate of -5.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 1.57B | -20.68% |
| Dec 31, 2025 | 1.98B | -8.66% |
| Dec 31, 2024 | 2.17B | 2.47% |
| Dec 29, 2023 | 2.12B | 6.41% |
| Dec 30, 2022 | 1.99B | -1.69% |
| Apr 19, 2022 | 2.03B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| G&E Herbal Biotechnology | 1.93B |
| Anti-Microbial Savior BioteQ | 1.89B |
| U-Neuron Biomedical | 1.86B |
| Sunny Pharmtech | 1.82B |
| Synbio Tech | 1.73B |
| TaiRx | 1.63B |
| Andros Pharmaceuticals Co.,Ltd | 1.56B |
| Great Novel Therapeutics Biotech & Medicals | 1.49B |